Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × abemaciclib × Clear all

NCT04010357 2025-12-02

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Phase 2 Active not recruiting

Small Cell Lung Carcinoma